ArticleTherapeutic advances in hematology2025

Real-world treatment outcome and toxicity analysis of inotuzumab ozogamicin in adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: multicenter prospective observational study.

Jae-Ho Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.